Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 201–300 of 759
The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease
Knez, E., Wzorek, K., Folwarski, M., Kaźmierczak-Siedlecka, K., Stachowska, L., Przewłócka, K., Stachowska, E., & Skonieczna‐Żydecka, K. (2021) · Nutrients · doi:10.3390/nu13072125 · Cited by 46
Bredeck, G., Halamoda‐Kenzaoui, B., Bogni, A., Lipsa, D., & Bremer‐Hoffmann, S. (2021) · Environment International · doi:10.1016/j.envint.2021.106921 · Cited by 42
Wang, T., Shi, C., Wang, S., Zhang, Y., Wang, S., Ismael, M., Zhang, J., Wang, X., & Lü, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07316 · Cited by 43
Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease
Özsoy, M., Stummer, N., Zimmermann, F., Feichtinger, R. G., Sperl, W., Weghuber, D., & Schneider, A.-M. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac024 · Cited by 43
Adherens junction proteins on the move—From the membrane to the nucleus in intestinal diseases
Lessey, L. R., Robinson, S. C., Chaudhary, R., & Daniel, J. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.998373 · Cited by 43
“Digestion, waste elimination and nutrient absorption occurs over the folded epithelia of the small and large intestines (Michielan and D’Incà, 2015; Peterson and Artis, 2014).”
BackgroundCosta, C. M., de Carvalho, N. M., Oliveira, D., & Madureira, A. R. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6010023 · Cited by 46
Cochran, K., Lamson, N. G., & Whitehead, K. A. (2020) · PeerJ · doi:10.7717/peerj.8681 · Cited by 42
“Decreased intestinal barrier function is a critical factor in clinical IBD and the DSS colitis model due to the subsequent immune cell infiltration and inflammatory response (Eichele & Kharbanda, 2017; Michielan & Incà, 2015).”
BackgroundInfluentialKuai, Y., Liu, H., Liu, D., Liu, Y., Sun, Y., Xie, J., Sun, J., Fang, Y. H., Pan, H., & Han, W. (2020) · Theranostics · doi:10.7150/thno.43938 · Cited by 45
“Mice were monitored daily to determine their body weight and were checked for diarrhea and bleeding, which were scored as previously described [21].”
MethodCutone, A., Ianiro, G., Lepanto, M. S., Rosa, L., Valenti, P., di Patti, M. C. B., & Musci, G. (2020) · Cancers · doi:10.3390/cancers12123806 · Cited by 42
Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix
Porras, A. M., Zhou, H., Shi, Q., Xiao, X., Bank, J. L. C., Longman, R., & Brito, I. L. (2022) · mBio · doi:10.1128/mbio.02201-22 · Cited by 39
Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer
Caprara, G., Allavena, P., & Erreni, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144825 · Cited by 40
Lei, H., Crawford, M. S., & McCole, D. F. (2021) · Pharmaceuticals · doi:10.3390/ph14090840 · Cited by 41
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells
Burrello, C., Pellegrino, G., Giuffrè, M. R., Lovati, G., Magagna, I., Bertocchi, A., Cribiù, F. M., Boggio, F. L., Botti, F., Trombetta, E., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800229 · Cited by 43
TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
Burger, K., Jung, F., Baumann, A., Brandt, A., Staltner, R., Sánchez, V., & Bergheim, I. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102870 · Cited by 41
He, Y., Li, X., Yu, H., Ge, Y., Liu, Y., Qin, X., Jiang, M., & Wang, X. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00393 · Cited by 38
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
Pellegrini, C., Ippolito, C., Segnani, C., Dolfi, A., Errede, M., Virgintino, D., Fornai, M., Antonioli, L., Garelli, F., Nericcio, A., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104821 · Cited by 38
“The presence of enteric inflammation, besides contributing to bowel motor dysfunctions, can impair also the intestinal mucosal barrier with consequent alterations of intestinal permeability and secretory functions (Lechuga and Ivanov, 2017; Michielan and D'Inca, 2015).”
BackgroundCyanidin-3-O-glucoside protects intestinal epithelial cells from palmitate-induced lipotoxicity
Bashllari, R., Molonia, M. S., Muscarà, C., Speciale, A., Wilde, P. J., Saija, A., & Cimino, F. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1828480 · Cited by 38
“This in turn induces an immune response and consequently a chronic inflammation (Michielan and D’inca 2015).”
BackgroundThe food additive EDTA aggravates colitis and colon carcinogenesis in mouse models
Evstatiev, R., Červenka, A., Austerlitz, T., Deim, G., Baumgartner, M., Beer, A., Krnjic, A., Gmainer, C., Lang, M., Frick, A. P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84571-5 · Cited by 40
The role of fatty acids in Crohn's disease pathophysiology – An overview
Piotrowska, M., Binienda, A., & Fichna, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111448 · Cited by 37
Intestinal barrier functions in hematologic and oncologic diseases
Haroun, E., Kumar, P. A., Saba, L., Kassab, J. T., Ghimire, K. B., Dutta, D., & Lim, S. H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04091-w · Cited by 37
“They include inflammatory bowel disease [1], celiac disease [2], non-alcoholic steatohepatitis [3], diabetes mellitus [4], and autism [5].”
BackgroundNong, K., Qin, X., Liu, Z., Wang, Z., Wu, Y., Zhang, B., Chen, W., Fang, X., Liu, Y., Wang, X., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155523 · Cited by 37
Wang, D., Sun, M., Zhang, Y., Chen, Z., Zang, S., Li, G., Gao, L., Clark, A. R., Huang, J., & Si, L. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153293 · Cited by 36
Liu, Y., Wu, J., Chen, L., Wu, X. Y., Gan, Y., Xu, N., Li, M., Luo, H., Guan, F., Su, Z., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114260 · Cited by 37
Tak, L.-J., Kim, H.-Y., Ham, W.-K., Agrahari, G., Seo, Y., Yang, J. W., Yang, J. W., An, E.-J., Lee, M. J., Kim, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126431 · Cited by 36
What is the leaky gut? Clinical considerations in humans
Camilleri, M. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000778 · Cited by 42
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 45
Coated Bacteria: Advanced Living Materials for Microbial Therapy
Cao, Z., & Liu, J. (2024) · Accounts of Materials Research · doi:10.1021/accountsmr.4c00116 · Cited by 35
Colwill, M., Povlsen, S., Pollok, R., Patel, K., Goodhand, J., Ahmad, T., & Honap, S. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf167 · Cited by 40
Wang, X., Cheng, K., Liu, Z., Sun, Y., Zhou, L., Xu, M., Dai, X., Xiong, Y., & Zhang, H. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153804 · Cited by 36
Zhang, L., Lü, W., Lu, C. C., Guo, Y., Chen, X., Chen, J., Xu, F., Wan, H., & Dong, H. F. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.001 · Cited by 38
“292 Although numerous studies on IBD focused on immune cell infiltration and compromised intestinal epithelial barrier function [19,20], little is known about the involvement of mesenteric circulation in IBD.”
BackgroundHirata, Y., Ihara, S., & Koike, K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.044 · Cited by 38
Carbonne, C., Chadi, S., Kropp, C., Molimard, L., Chain, F., Langella, P., & Martín, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1270974 · Cited by 39
Wilbrink, J., Bernards, N., Mujagic, Z., van Avesaat, M. H. P., Pijls, K. E., Klaassen, T., van Eijk, H. M. H., Nienhuijs, S. W., Stronkhorst, A., Wilms, E., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0492-z · Cited by 34
Jiang, P., Lai, S., Wu, S., Zhao, X., & Chen, W.-H. (2020) · BMC Genomics · doi:10.1186/s12864-020-6749-z · Cited by 36
“Compromised intestinal barrier (CIB) has been shown to associate with many intestinal diseases, including inflammatory bowel diseases (IBD) [20] and CRC [21, 22].”
BackgroundHow is small bowel permeability in endometriosis patients? a case control pilot study
Viganò, D., Zara, F., Pinto, S. W. L., Loddo, E., Casula, L., Soru, M. B., D’Ancona, G., D’Alterio, M. N., GIULIANI, C., Angioni, S. L., et al. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1766440 · Cited by 35
Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis
So, J., & Tam, L. (2020) · Microorganisms · doi:10.3390/microorganisms8111727 · Cited by 37
“Dysregulation of the interactions between luminal epithelial cells, immune cells and luminal microbiome increases bowel permeability, resulting in luminal antigen translocation which triggers immunological responses such as leukocyte recruitment and a release of soluble mediators, leading to intestinal inflammation [1…”
BackgroundMählmann, L., Gerber, M., Furlano, R. I., Légeret, C., Kalak, N., Holsboer‐Trachsler, E., & Brand, S. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0721-7 · Cited by 34
“Patients with IBD might lose albumin due to increased gut permeability, even during symptom-free episodes [36].”
BackgroundCytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway
Li, L., Huang, S., Wang, H., Chao, K., Ding, L., Feng, R., Qiu, Y., Feng, T., Zhou, G., Hu, J., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy187 · Cited by 36
Navarro, P., Gutiérrez‐Ramírez, L., Tejera‐Muñoz, A., Arias, Á., & Lucendo, A. J. (2023) · Nutrients · doi:10.3390/nu15214507 · Cited by 37
Uwada, J., Yazawa, T., Islam, M. T., Khan, M. R. I., Krug, S. M., Fromm, M., Karaki, S.-I., Suzuki, Y., Kuwahara, A., Yoshiki, H., et al. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.04.007 · Cited by 32
Chi, J. H., Kim, Y. H., Sohn, D. H., Seo, G. S., & Lee, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.050 · Cited by 34
Filannino, P., Cagno, R. D., Vincentini, O., Pinto, D., Polo, A., Maialetti, F., Porrelli, A., & Gobbetti, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.622091 · Cited by 32
Toto, B., Refosco, A., O’Keeffe, M., Barkhald, Ø. H., Brønstad, A., Lied, G. A., Yadetie, F., Goksøyr, A., Kögel, T., & Dierkes, J. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.09.002 · Cited by 32
Melatonin and inflammatory bowel disease: From basic mechanisms to clinical application
Vaghari‐Tabari, M., Moein, S., Alipourian, A., Qujeq, D., Malakoti, F., Alemi, F., Yousefi, B., & Khazaie, S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.12.007 · Cited by 33
Masu, Y., Kanazawa, Y., Kakuta, Y., Shimoyama, Y., Onodera, M., Naito, T., Moroi, R., Kuroha, M., Kimura, T., Shiga, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96289-5 · Cited by 32
Speciale, A., Muscarà, C., Molonia, M. S., Toscano, G., Cimino, F., & Saija, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.809938 · Cited by 33
Low potassium disrupt intestinal barrier and result in bacterial translocation
Wu, H., Huang, R., Fan, J., Luo, N., & Yang, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03499-0 · Cited by 32
“Permeability is one component of intestinal barrier function [14].”
BackgroundJin, X., Hu, Y., Lin, T., Gao, F., Xu, Z., Hou, X., Yin, Y., Kan, S., Zhu, H., & Chen, D. (2023) · Food & Function · doi:10.1039/d2fo03408e · Cited by 32
Heifert, T. A., Susi, A., Hisle-Gorman, E. J., Erdie-Lalena, C. R., Gorman, G. H., Min, S. B., & Nylund, C. M. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001282 · Cited by 33
Wright, C. W., Li, N., Shaffer, L., Hill, A. D., Boyer, N. C., Alves, S. E., Venkataraman, S., Biswas, K., Lieberman, L. A., & Mohammadi, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-43656-z · Cited by 31
Liu, Y., Tang, W., Ao, J., Zhang, J., & Feng, L. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151644 · Cited by 31
de Oliveira, N. M. T., da Luz, B. B., Schneider, V. S., Filho, H. B. D. C., Sousa, P. S. D. A., Werner, M. F. D. P., de Souza, M. H. L. P., Rocha, J. A., Nicolau, L. A. D., Cordeiro, L. M. C., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111291 · Cited by 30
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Hu, W., Huang, L., Zhou, Z., Yin, L., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.743454 · Cited by 34
“Notably, DSS and C. albicans caused a significant increase in IL-6 and IFN-g in both the serum and colon, and these changes could be reversed by DADS treatment (Figures 4C, D).”
BackgroundInfluentialThe Association of Inflammatory Gut Diseases with Neuroinflammatory and Auditory Disorders
Kociszewska, D., & Vlajkovic, S. M. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1402008 · Cited by 32
“IBD is an umbrella term used to label two disorders that involve chronic inflammation of the gastrointestinal tract (GIT): Crohn’s disease (CD) and ulcerative colitis (UC) [11].”
BackgroundBoscaini, S., Cabrera‐Rubio, R., Golubeva, A. V., Nychyk, O., Fülling, C., Speakman, J. R., Cotter, P. D., Cryan, J. F., & Nilaweera, K. N. (2021) · Physiological Reports · doi:10.14814/phy2.14867 · Cited by 30
Csáki, K. F., & Sebestyén, É. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.04.001 · Cited by 28
The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease
O’Connell, L., Winter, D. C., & Aherne, C. M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.624045 · Cited by 31
Power, N., Turpin, W., Espin‐Garcia, O., Smith, M. I., & Croitoru, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.645303 · Cited by 28
Sex differences in zonulin in affective disorders and associations with current mood symptoms
Maget, A., Dalkner, N., Hamm, C., Bengesser, S., Fellendorf, F. T., Platzer, M., Queissner, R., Birner, A., Lenger, M., Mörkl, S., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.021 · Cited by 32
Pathophysiological role of ion channels and transporters in gastrointestinal mucosal diseases
Deng, Z., Zhao, Y., Ma, Z., Zhang, M., Wang, H., Yi, Z., Tuo, B., Li, T., & Liu, X. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04011-5 · Cited by 32
Turpin, W., Espin‐Garcia, O., Bedrani, L., Madsen, K. L., Meddings, J. B., Garay, J. A. R., Silverberg, M. S., Smith, M. I., Griffiths, A. M., Moayyedi, P., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz116 · Cited by 29
Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
Więcek, M., Panufnik, P., Kaniewska, M. A., Lewandowski, K., & Rydzewska, G. M. (2022) · Nutrients · doi:10.3390/nu14214562 · Cited by 27
Lacy, B. E., & Cangemi, D. J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002887 · Cited by 29
“Transport in and out of the gastrointestinal lumen is regulated by the mucosa, which consists of a monolayer of epithelial cells and a secreted mucinous layer overlying the epithelial cell layer (15,16).”
BackgroundLacerda, J. D. H. L. F., Lagos, A. C., Carolino, E., Silva-Herdade, A. S., Silva, M., & Guerreiro, C. S. (2021) · Nutrients · doi:10.3390/nu13020642 · Cited by 29
Lim, J.-M., Yoo, H. J., & Lee, K. (2022) · Marine Drugs · doi:10.3390/md20090580 · Cited by 28
“Intestinal barrier dysfunction, often called “leaky gut”, makes individuals vulnerable to various chronic inflammatory intestinal disorders, including diabetes and inflammatory bowel disease (IBD) [1].”
BackgroundInfluentialGong, Q., Sun, Y., Liu, L., Pu, C., & Guo, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36812 · Cited by 29
“Intestinal barrier dysfunction is characterized by an elevation in intestinal permeability, which enables the passage of enteric toxins Q. Gong et al. or pathogens [41,42].”
BackgroundApplication of chitosan as nano carrier in the treatment of inflammatory bowel disease
Liu, X., Dong, Y., Wang, C., & Guo, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134899 · Cited by 30
Anthocyanins and intestinal barrier function: a review
Valdez, J. C., & Bolling, B. W. (2019) · Journal of Food Bioactives · doi:10.31665/jfb.2019.5175 · Cited by 29
“Normal immunoregulatory function, which could moderate the severity and longevity of the immune response is also impaired in IBD (Michielan and D’Incà, 2015).”
BackgroundStewart, F., Cummins, G., Turcanu, M. V., Cox, B. F., Prescott, A. R., Clutton, E. R., Newton, I. P., Desmulliez, M. P. Y., Thanou, M., Mulvana, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82240-1 · Cited by 27
Joo, H., Oh, M., Kang, J. Y., Park, H. S., Chae, D., Kim, J., Lee, J., Yoo, H. M., Choi, U., Kim, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9020209 · Cited by 26
Maruyama, B. Y., Ma, C., Panaccione, R., & Kotze, P. G. (2021) · Inflammatory Intestinal Diseases · doi:10.1159/000515959 · Cited by 26
Murugan, S., Bethapudi, B., Raghunandhakumar, S., Purusothaman, D., Nithyanantham, M., Mundkinajeddu, D., & Talkad, M. S. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03500-1 · Cited by 33
Interaction of Companilactobacillus crustorum MN047-derived bacteriocins with gut microbiota
Wang, T., Wang, S., Dong, S., Zhang, Y., Ismael, M., Wang, S., Shi, C., Yang, J., Wang, X., & Lü, X. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.133730 · Cited by 26
Husnoo, N., Gana, T., Hague, A. G., Khan, Z. M., Morgan, J. L., Wyld, L., & Brown, S. R. (2023) · Colorectal Disease · doi:10.1111/codi.16502 · Cited by 27
Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds
Hadian, Y., Fregoso, D. R., Nguyen, C., Bagood, M. D., Dahle, S. E., Gareau, M. G., & Isseroff, R. R. (2020) · Wound Repair and Regeneration · doi:10.1111/wrr.12800 · Cited by 30
Sympathetic-Mediated Intestinal Cell Death Contributes to Gut Barrier Impairment After Stroke
Kumar, K. P., McKay, L. D., Nguyen, H., Kaur, J., Wilson, J. L., Suthya, A. R., McKeown, S. J., Abud, H. E., & Wong, C. H. Y. (2023) · Translational Stroke Research · doi:10.1007/s12975-023-01211-y · Cited by 28
“Indeed, localised inflammation and hypoperfusion have been identified as mediators of epithelial structure alterations associated with numerous intestinal diseases characterised by compromised gut barrier integrity [38, 39].”
Li, D., Shangguan, J., Yu, F., Lin, G., Pan, H., Zhang, M., Lin, H., Chen, B., Xu, H., & Hu, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c15684 · Cited by 25
Yue, N., Hu, P., Tian, C., Chen, K., Zhao, H., Zhang, Y., Yao, J., Wei, Y., Li, D., & Wang, L. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s492079 · Cited by 30
Shi, Y., He, C., Ma, C., Yu, T., Cong, Y., Cai, W., & Liu, Z. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.95 · Cited by 27
Mashaqi, S., Rangan, P., Saleh, A. A., Abraham, I. L., Gozal, D., Quan, S. F., & Parthasarathy, S. (2023) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2023.101774 · Cited by 26
Nonaka, S., Okamoto, R., Katsuta, Y., Kanetsuki, S., & Nakanishi, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149783 · Cited by 28
Huai, M., Pei, M., Chen, J., Duan, X., Zhu, Y., Yang, F., & Ge, W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03007-0 · Cited by 26
“On the other hand, in high-ROS-environ-ment, DNA damage, protein carbonylation, and lipid peroxidation could be induced, or even severely lead to intestinal epithelial damage, thus expanding gut permeability and recruiting immune cells [12].”
Wrba, L., Palmer, A., Braun, C., & Huber-Lang, M. S. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001654 · Cited by 25
“17 Permeability changes are also observed in patients with Crohn disease and in some of their first-degree relatives, indicating some genetic imprint of barrier dysfunction.(18,19) Experimental data indicate that Clostridium difficile–associated colitis may change the GBB permeability,(20) whereas clinical data on thi…”
BackgroundAge-Related Deterioration of Mitochondrial Function in the Intestine
Schneider, A.-M., Özsoy, M., Zimmermann, F., Feichtinger, R. G., Mayr, J. A., Kofler, B., Sperl, W., Weghuber, D., & Mörwald, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4898217 · Cited by 25
Assessment of Risk Factors for the Occurrence of a High-Output Ileostomy
Seifarth, C., Augustin, L. N., Lehmann, K. S., Stroux, A., Lauscher, J. C., Kreis, M. E., & Holmer, C. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.642288 · Cited by 28
Zhuang, X., Chen, B., Huang, S., Han, J., Zhou, G., Xu, S., Chen, M., Zeng, Z., & Zhang, S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103846 · Cited by 24
“MiR-145-5p agomir and its corresponding negative control at a dose of 10 mg/kg were administered to TNBS-induced colitis mice via intraperitoneal injection on days 8, 9, and 10.”
Wan, H., Chen, X. Y., Zhang, F., Chen, J., Chu, F., Sellers, Z. M., Xu, F., & Dong, H. F. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101847 · Cited by 24
“Hallmarks of the disease include immune cell infiltration and activation in the mucosa leading to inflammation and ulceration of the intestinal wall (3, 4).”
BackgroundCuddihey, H., Cavin, J., Keenan, C. M., Wallace, L. E., Vemuri, K. V., Makriyannis, A., MacNaughton, W. K., & Sharkey, K. A. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00341.2021 · Cited by 26
Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside
Zhang, L., Yang, L., & Chu, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00408 · Cited by 32
Zailani, H., Satyanarayanan, S. K., Liao, W.-C., Liao, H.-F., Huang, S., Gałecki, P., Su, K., & Chang, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072653 · Cited by 25
Measurement of gut permeability using fluorescent tracer agent technology
Dorshow, R. B., Hall-Moore, C. M., Shaikh, N., Talcott, M., Faubion, W. A., Rogers, T. E., Shieh, J. J., Debreczeny, M. P., Johnson, J. R., Dyer, R. B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09971-y · Cited by 24
Pradhan, D., Singh, R., Tyagi, A., Rashmi, H. M., Batish, V. K., & Grover, S. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9489-5 · Cited by 24
Buzza, M. S., Johnson, T. A., Conway, G. D., Martin, E. W., Mukhopadhyay, S., Shea‐Donohue, T., & Antalis, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771469 · Cited by 26
Fan, J., Li, T., & Zhao, X. (2020) · RSC Advances · doi:10.1039/d0ra04162a · Cited by 23
Rapa, S. F., Paola, R. D., Cordaro, M., Siracusa, R., D’Amico, R., Fusco, R., Autore, G., Cuzzocrea, S., Stuppner, H., & Marzocco, S. (2021) · Biomedicines · doi:10.3390/biomedicines9010067 · Cited by 24
Proteomics Analysis in Dairy Products: Cheese, a Review
Bouroutzika, E. V., Proikakis, S., Anagnostopoulos, A. K., Katsafadou, A. I., Fthenakis, G. C., & Tsangaris, G. T. (2021) · Applied Sciences · doi:10.3390/app11167622 · Cited by 25
Wilson, E. J., Natesh, N. S., Ghadermazi, P., Pothuraju, R., Marudhupandiyan, S., Prajapati, D. R., Pandey, S., Kaifi, J. T., Dodam, J. R., Bryan, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010539 · Cited by 25
Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1
Li, J., Zuo, L., Tian, Y., He, Y., Zhang, Z., Guo, P., Ge, Y., & Hu, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14471 · Cited by 23
The association of zonulin-related proteins with prevalent and incident inflammatory bowel disease
Wang, X., Memon, A. A., Palmér, K., Hedelius, A., Sundquist, J., & Sundquist, K. (2022) · BMC Gastroenterology · doi:10.1186/s12876-021-02075-y · Cited by 23
“The intestinal barrier dysfunction may increase permeability, which allows for the interaction between exterior antigens and mucosal immune system, and then lead to a dysregulated response [7].”
Background
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.